Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratification.
Anurathapan U, Pakakasama S, Mekjaruskul P, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Pongtanakul B, Rujkijyanont P, Meekaewkunchorn A, Sruamsiri R, Ungkanont A, Issaragrisil S, Andersson BS, Hongeng S. Anurathapan U, et al. Among authors: issaragrisil s. Biol Blood Marrow Transplant. 2014 Dec;20(12):2066-71. doi: 10.1016/j.bbmt.2014.07.016. Epub 2014 Jul 23. Biol Blood Marrow Transplant. 2014. PMID: 25064743 Free PMC article.
Bone marrow transplantation for thalassemia in Thailand.
Issaragrisil S, Visudhisakchai S, Suvatte V, Chandanayingyong D, Piankijagum A, Mahasandana C, Tanphaichitr VS. Issaragrisil S, et al. Bone Marrow Transplant. 1993;12 Suppl 1:42-4. Bone Marrow Transplant. 1993. PMID: 8374559
Stem cell transplantation for thalassemia.
Issaragrisil S. Issaragrisil S. Int J Hematol. 2002 Aug;76 Suppl 1:307-9. doi: 10.1007/BF03165269. Int J Hematol. 2002. PMID: 12430869 Review.
Use of in vivo gene expression of isolated bone marrow mesenchymal stromal cells to study the pathophysiology of osteoporosis in patients with severe thalassemia.
Hongeng S, Wongborisuth C, Disthabanchong S, Pakakasama S, Mahachoklertwattana P, Ongphiphadhanakul B, Issaragrisil S, Rajatanavin R. Hongeng S, et al. Among authors: issaragrisil s. J Pediatr Hematol Oncol. 2011 Apr;33(3):179-84. doi: 10.1097/MPH.0b013e318205e24d. J Pediatr Hematol Oncol. 2011. PMID: 21325969
Pretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease control.
Anurathapan U, Pakakasama S, Rujkijyanont P, Sirachainan N, Songdej D, Chuansumrit A, Sirireung S, Charoenkwan P, Jetsrisuparb A, Issaragrisil S, Ungkanont A, Sruamsiri R, Srisala S, Andersson BS, Hongeng S. Anurathapan U, et al. Among authors: issaragrisil s. Biol Blood Marrow Transplant. 2013 Aug;19(8):1259-62. doi: 10.1016/j.bbmt.2013.04.023. Epub 2013 May 3. Biol Blood Marrow Transplant. 2013. PMID: 23648235 Free PMC article. Clinical Trial.
174 results